A Pill Version of Wegovy Wins U.S. Approval, Signaling a New Era for Weight-Loss Drugs
- Miguel Virgen, PhD Student in Business
- 1 day ago
- 4 min read
The approval of a pill version of Wegovy for use in the United States marks a pivotal moment in the rapidly evolving market for weight-loss medications. Until now, Wegovy has been widely known as a once-weekly injectable drug, part of a powerful class of GLP-1 medications that have reshaped how obesity is treated. With regulators now clearing an oral alternative, Novo Nordisk is opening the door to a far broader audience of patients who may have hesitated to start treatment due to fear of needles, inconvenience, or stigma associated with injections.
Want to read more?
Subscribe to doctorsinbusinessjournal.com to keep reading this exclusive post.
